Home/Filings/4/0001645572-19-000001
4//SEC Filing

Eyre Brik V 4

Accession 0001645572-19-000001

CIK 0000010456other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:07 PM ET

Size

13.8 KB

Accession

0001645572-19-000001

Insider Transaction Report

Form 4
Period: 2019-02-19
Eyre Brik V
CVP, Hospital Products
Transactions
  • Tax Payment

    Common Stock, $1 par value

    2019-02-19$73.47/sh18,255$1,341,19571,475 total
  • Award

    Common Stock, $1 par value

    2019-02-19+2,69177,998 total
  • Award

    Common Stock, $1 par value

    2019-02-19+25,27389,730 total
  • Award

    Common Stock, $1 par value

    2019-02-19+5,17464,457 total
  • Award

    Common Stock, $1 par value

    2019-02-19+3,83275,307 total
Footnotes (5)
  • [F1]Represents shares awarded from the performance share unit award granted on March 3, 2016 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2016 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's OM during the Janaury 1, 2018 to December 31, 2018 performance period. These shares have vested as the relevant three-year performance period January 1, 2016 to December 31, 2018 (the Three-Year Performance Period) has ended.
  • [F2]Represents shares awarded from the 2016 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR), formerly known as Growth in Shareholder Value, performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended.
  • [F3]Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2016, 2017, and 2018 as part of the 2016 PSUs.
  • [F4]Represents shares earned from the performance share unit award granted on March 2, 2017 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2018 to December 31, 2018. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2017 through December 31, 2019).
  • [F5]Represents shares earned from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2018 through December 31, 2018. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2018 through December 31, 2020).

Issuer

BAXTER INTERNATIONAL INC

CIK 0000010456

Entity typeother

Related Parties

1
  • filerCIK 0001645572

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:07 PM ET
Size
13.8 KB